In vivo Bruton’s tyrosine kinase inhibition attenuates alcohol-associated liver disease by regulating CD84-mediated granulopoiesis
Prashanth Thevkar Nagesh(New York University), Bruce Barton(University of Massachusetts Chan Medical School), Gyöngyi Szabó(Beth Israel Deaconess Medical Center), Srinivasan Dasarathy(Cleveland Clinic), Mack C. Mitchell(Southwestern Medical Center), Craig J. McClain(University of Louisville), Veronika Brezáni(Beth Israel Deaconess Medical Center), Christopher Copeland(Beth Israel Deaconess Medical Center), Samer Gawrieh(Indiana University School of Medicine), Mrigya Babuta(University of Hyderabad), Ramón Bataller(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Eleni Kanata(Max Planck Institute for Molecular Genetics), John M. Asara(Beth Israel Deaconess Medical Center), Ioannis S. Vlachos(Broad Institute), Vijay H. Shah(Mayo Clinic in Arizona), Martí Ortega‐Ribera(Beth Israel Deaconess Medical Center), Wanzhu Tu(Indiana University Health), Z. Gordon Jiang(Beth Israel Deaconess Medical Center), Radhika Joshi(Beth Israel Deaconess Medical Center), Yuan Zhuang(Zhongshan Hospital), Aditi Ashish Datta(Beth Israel Deaconess Medical Center), Arun Sanya, Yun‐Cheng Hsieh(Beth Israel Deaconess Medical Center), Naga Chalasani(Indiana University – Purdue University Indianapolis), Adriana Ramos(Beth Israel Deaconess Medical Center), Yeonhee Cho(Beth Israel Deaconess Medical Center), Arman Patel(Beth Israel Deaconess Medical Center), Jeeval Mehta(Beth Israel Deaconess Medical Center)
Cited by 8
Related Papers
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O <sub>2</sub> Sensing
|Science|2001|4.7k
Liver fibrosis
|Journal of Clinical Investigation|2005|4.7k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k